Katalog der Deutschen Nationalbibliothek


Suchformular zurücksetzen  
 
Expertensuche ?
 
eingeschränkt auf
- Materialarten:  Online Ressourcen
Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
 
 


Ergebnis der Suche nach: "113078676"
im Bestand: Gesamter Bestand

1 - 5 von 5
<< < > >>


Online Ressourcen 1 Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
Sommerhäuser, Greta. - Freiburg : Universität, 2024
Online Ressource
Artikel 2 A Lentiviral CXCR4 Overexpression and Knockdown Model in Colorectal Cancer Cell Lines Reveals Plerixafor-Dependent Suppression of SDF-1α-Induced Migration and Invasion
Enthalten in Oncology research and treatment Bd. 34, 2011, Nr. 10: 502-508
Online Ressource
Artikel 3 Relevance of Peripheral Blood Progenitor Cell Counts during Steady-State Hematopoiesis to Estimate the Number of Progenitor Cells Mobilized following Granulocyte Colony-Stimulating Factor-Supported Chemotherapy
Enthalten in Transfusion medicine and hemotherapy Bd. 26, 1999, Nr. 2: 103-109
Online Ressource
Artikel 4 Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide
Enthalten in Annals of hematology Bd. 83, 19.11.2003, Nr. 7, date:7.2004: 467-470
Online Ressource
Artikel 5 Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
Enthalten in BMC cancer Bd. 22, 27.7.2022, Nr. 1, date:12.2022: 1-14
Online Ressource


1 - 5 von 5
<< < > >>


E-Mail-IconAdministration